Boehringer Ingelheim and Vanderbilt University expand partnership to develop novel treatment approaches for cancer
Mar. 14, 2018—New agreement will pursue therapies targeting MCL1 (myeloid cell leukemia 1), which is highly prevalent in many difficult-to-treat cancers.
Jan. 8, 2018—Under the terms of the licensing agreement, Lundbeck has exclusively licensed rights to compounds developed at Vanderbilt that act on a receptor in the brain that has been implicated in schizophrenia.
Feb. 22, 2017—Scientists at Vanderbilt University have created a three-dimensional organ-on-a-chip that can mimic the heart’s amazing biomechanical properties in order to study cardiac disease, develop heart drugs.
Apr. 22, 2016—A startup veteran and investor whose ventures range from retail to manufacturing joined Vanderbilt University this spring as the inaugural executive director of the newly created Innovation Center. Robert Grajewski joined Vanderbilt as the Evans Family Executive Director of the Innovation Center on April 1. The Innovation Center, set to open late summer, will support a maker culture that encourages innovation and creativity and bolsters implementation of the four intersecting themes that make up the university’s Academic Strategic Plan.
Feb. 1, 2016—Startup veteran Robert Grajewski has been chosen as the inaugural executive director of the newly created Vanderbilt University Innovation Center.